Free Trial
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel
OTCMKTS:TRUMY

Terumo 5/15/2026 Earnings Report

Terumo logo
$15.04 -0.10 (-0.66%)
As of 05/29/2026 03:59 PM Eastern
ProfileEarnings HistoryForecast

Terumo EPS Results

Actual EPS
$0.11
Consensus EPS
$0.11
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Terumo Revenue Results

Actual Revenue
$1.90 billion
Expected Revenue
$1.84 billion
Beat/Miss
Beat by +$55.09 million
YoY Revenue Growth
N/A

Terumo Announcement Details

Quarter
Date
5/15/2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Terumo's next earnings date is estimated for Thursday, August 6, 2026, based on past reporting schedules.

Conference Call Resources

Terumo Earnings Headlines

Terumo ADR Stock Price History
May 17, 2026  |  investing.comhttps://www.investing.com/equities/terumo-adr-historical-data
Terumo Corporation (TRUMY) Q4 2026 Earnings Call Transcript
May 17, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4905155-terumo-corporation-trumy-q4-2026-earnings-call-transcript
Elon Musk’s $1 Quadrillion AI IPO
$1 quadrillion would be enough to send a $2.8 million check to every man, woman, and child in America. That is the scale of what analysts are calling the biggest AI IPO in history.And right now, you can claim a stake before the company goes public, starting with just $500.Elon Musk is predicting this investment could climb 1,000x from here. Early access is available today.tc pixel
May 31 at 1:00 AM  |  Brownstone Research (Ad)
Terumo Corporation (TRUMY) Q3 2026 Earnings Call Transcript
February 13, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4870046-terumo-corporation-trumy-q3-2026-earnings-call-transcript
Terumo Corporation (TRUMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
January 13, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4859067-terumo-corporation-trumy-presents-at-44th-annual-j-p-morgan-healthcare-conference-transcript
Terumo Corporation (TRUMY) Q2 2026 Earnings Call Transcript
November 12, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4842354-terumo-corporation-trumy-q2-2026-earnings-call-transcript
See More Terumo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Terumo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Terumo and other key companies, straight to your email.

About Terumo

Terumo (OTCMKTS:TRUMY) Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags. Through its Terumo BCT subsidiary, the company also provides apheresis, blood component management and cell therapy technologies used by blood banks, transfusion services and cell-therapy developers. Terumo’s portfolio emphasizes single-use medical devices and clinically oriented systems designed to improve procedural outcomes and patient safety.

Founded in the early 20th century and headquartered in Tokyo, Terumo has grown into a multinational supplier with operations and sales networks across Asia, the Americas and Europe. The company distributes products globally through a combination of regional subsidiaries, direct sales teams and distribution partners, serving hospitals, specialty clinics and blood centers. As a publicly listed Japanese corporation, Terumo also maintains an American depositary receipt (ADR) listing that enables trading on overseas markets.

View Terumo Profile
Earnings Tools